These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

915 related articles for article (PubMed ID: 24636240)

  • 1. Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution.
    Hung MJ; Su TH; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Tsai CP; Shen PS; Chen GD
    J Sex Med; 2014 Sep; 11(9):2256-63. PubMed ID: 24636240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.
    Liang CC; Lin YH; Hsieh WC; Huang L
    Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis.
    Hung MJ; Tsai CP; Lin YH; Huang WC; Chen GD; Shen PS
    Taiwan J Obstet Gynecol; 2019 May; 58(3):417-422. PubMed ID: 31122535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of intravesical chondroitin-sulfate and combined hyaluronic-acid/chondroitin-sulfate therapy on female sexual function in bladder pain syndrome.
    Arslan B; Gönültaş S; Gökmen E; Özman O; Avci MA; Özdemir E
    Int Urogynecol J; 2019 Nov; 30(11):1857-1862. PubMed ID: 31254047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.
    Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC
    Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis.
    Gülpınar Ö; Esen B; Kayış A; Gökçe Mİ; Süer E
    Neurourol Urodyn; 2018 Jan; 37(1):257-262. PubMed ID: 28480984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparative analysis of intravesical sodium hyaluronate monotherapy and its combination with oral chondroitin sulfate in patietns with bladder pain syndrome/intersticial cystitis].
    Aboyan IA; Aboyan VE; Pavlov SV; Zinkovskaya OV; Pavlov DS
    Urologiia; 2019 Apr; (1):35-39. PubMed ID: 31184015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with treatment outcomes after intravesical hyaluronic acid therapy in women with refractory interstitial cystitis: A prospective, multicenter study.
    Tsai CP; Yang JM; Liang SJ; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Hung MJ
    J Chin Med Assoc; 2021 Apr; 84(4):418-422. PubMed ID: 33784267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual dysfunction in women with interstitial cystitis/bladder pain syndrome: Do onabotulinum toxin-A injections improve sexual function?
    Topcuoglu M; Karaburun MC; İbiş A; Gokce Mİ; Süer E; Gülpinar O
    Neurourol Urodyn; 2023 Mar; 42(3):607-614. PubMed ID: 36708358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Review and Meta-Analysis of Intravesical Hyaluronic Acid and Hyaluronic Acid/Chondroitin Sulfate Instillation for Interstitial Cystitis/Painful Bladder Syndrome.
    Pyo JS; Cho WJ
    Cell Physiol Biochem; 2016; 39(4):1618-25. PubMed ID: 27627755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis.
    Cervigni M; Sommariva M; Tenaglia R; Porru D; Ostardo E; Giammò A; Trevisan S; Frangione V; Ciani O; Tarricone R; Pappagallo GL
    Neurourol Urodyn; 2017 Apr; 36(4):1178-1186. PubMed ID: 27654012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amniotic bladder therapy: six-month follow up treating interstitial cystitis/bladder pain syndrome.
    Considine J; O'Hollaren K; Radoiu C; Madan R; Liaw A; Dhar N
    Can J Urol; 2024 Jun; 31(3):11898-11903. PubMed ID: 38912944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome.
    Bosch PC
    Eur Urol; 2018 Nov; 74(5):623-630. PubMed ID: 30072210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
    Lee CL; Kuo HC
    Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of onabotulinum toxin-A injection on sexual function in women with refractory interstitial cystitis/bladder pain syndrome: A prospective study.
    Karaburun MC; Kubilay E; Öztuna D; Gökçe Mİ; Süer E; Gülpınar Ö
    Low Urin Tract Symptoms; 2024 Mar; 16(2):e12511. PubMed ID: 38527461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
    Kuo HC
    Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Feasibility of Intravesical Instillation of Botulinum Toxin-A in Hydrogel-based Slow-release Delivery System in Patients With Interstitial Cystitis-Bladder Pain Syndrome: A Pilot Study.
    Rappaport YH; Zisman A; Jeshurun-Gutshtat M; Gerassi T; Hakim G; Vinshtok Y; Stav K
    Urology; 2018 Apr; 114():60-65. PubMed ID: 29307733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical hyaluronic acid for interstitial cystitis/painful bladder syndrome: a comparative randomized assessment of different regimens.
    Lai MC; Kuo YC; Kuo HC
    Int J Urol; 2013 Feb; 20(2):203-7. PubMed ID: 22925498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome.
    Nickel JC; Hanno P; Kumar K; Thomas H
    Urology; 2012 Jun; 79(6):1220-4. PubMed ID: 22516357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
    Chuang YC; Kuo HC
    J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.